Briefing Information for the July 13, 2017 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance.
Morning Session - FDA
- FDA Briefing Information for the July 13, 2017 Meeting of the Oncologic Drugs Advisory Committee (AM Session)
- Errata to the FDA Briefing Information for the July 13, 2017 Meeting of the Oncologic Drugs Advisory Committee
Amgen Inc.
- Amgen Briefing Information for the July 13, 2017 Meeting of the Oncologic Drugs Advisory Committee
- Errata to the Amgen Briefing Information for the July 13, 2017 Meeting of the Oncologic Drugs Advisory Committee